KROS•benzinga•
Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan
Summary
Keros Therapeutics launches strategic review and adopts rights plan after investor activity signals potential changes in company control.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 10, 2025 by benzinga